Artificial Intelligence and Medical Products – FDA.gov
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Artificial Intelligence (AI) is a machine-based system that can, for a given set of human-defined objectives, make predictions, recommendations, or decisions influencing real or virtual environments. AI systems use machine- and human-based inputs to perceive real and virtual environments; abstract such perceptions into models through analysis in an automated manner; and use model inference to formulate options for information or action. AI includes machine learning, which is a set of techniques that can be used to train AI algorithms to improve performance of a task based on data.
AI has emerged as a transformative force. The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation’s food supply, cosmetics, and products that emit radiation. This landing page serves as your gateway to a wealth of information, resources, and insights into the intersection of AI and medical products. Learn more about how the FDA is shaping the future of health care through the responsible and innovative integration of AI.
For specific information related to biological products, please visit:
For specific information related to drug products, please visit:
For specific information related to devices, please visit:
For more information on the laws, regulations, executive orders, and memoranda that drives HHS’s AI efforts, please visit:
Guidance documents, discussion papers, constituent updates, and reports.
This article was autogenerated from a news feed from CDO TIMES selected high quality news and research sources. There was no editorial review conducted beyond that by CDO TIMES staff. Need help with any of the topics in our articles? Schedule your free CDO TIMES Tech Navigator call today to stay ahead of the curve and gain insider advantages to propel your business!
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Artificial Intelligence (AI) is a machine-based system that can, for a given set of human-defined objectives, make predictions, recommendations, or decisions influencing real or virtual environments. AI systems use machine- and human-based inputs to perceive real and virtual environments; abstract such perceptions into models through analysis in an automated manner; and use model inference to formulate options for information or action. AI includes machine learning, which is a set of techniques that can be used to train AI algorithms to improve performance of a task based on data.
AI has emerged as a transformative force. The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation’s food supply, cosmetics, and products that emit radiation. This landing page serves as your gateway to a wealth of information, resources, and insights into the intersection of AI and medical products. Learn more about how the FDA is shaping the future of health care through the responsible and innovative integration of AI.
For specific information related to biological products, please visit:
For specific information related to drug products, please visit:
For specific information related to devices, please visit:
For more information on the laws, regulations, executive orders, and memoranda that drives HHS’s AI efforts, please visit:
Guidance documents, discussion papers, constituent updates, and reports.
This article was autogenerated from a news feed from CDO TIMES selected high quality news and research sources. There was no editorial review conducted beyond that by CDO TIMES staff. Need help with any of the topics in our articles? Schedule your free CDO TIMES Tech Navigator call today to stay ahead of the curve and gain insider advantages to propel your business!
